Study identifier:D9612L00011
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A study to assess whether maintenance treatment with esomeprazole 20mg od is at least as effective as lansoprazole 30mg od in patients with reflux disease - A 3 month, randomised, double blind, double dummy, multicenter study
gastrointestinal diseases
Phase 4
-
-
-
-
Interventional
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|